Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Therapy With Fish Oil and Fenofibrate for Hypertriglyceridemia in HIV Patients on HAART
NCT00076518Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of fenofibrate and fish oil concentrate in hypertriglyceridemia (3 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Treatment response based on serum triglyceride levels at 18 weeks. Status: completed.
02
Drugs
fenofibratefish oil concentrate
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT00076518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00076518.